PharmaRadar360

PharmaRadar360

🇬🇧·2d agoResearch

Integrated multi-omics reveals ITGB2 drives the mesenchymal transition in glioblastoma via FAK signaling

Publisher

n
npj Precision Oncology

UK

This page provides publisher metadata, and related coverage to support discovery before sending readers to the original article.

Read original

At a glance

Publisher
npj Precision Oncology
Region
UK
Scope
Research
Published
September 14, 2026

Publisher context, original article off-platform

This page presents the title, publisher metadata, and related coverage. The publisher did not provide a public summary in this feed. Full-text reading stays on the publisher's original site.

Source route

Continue on nature.com

Leave the platform to read the original full article on the publisher site.

Source: npj Precision Oncology

Scope: Research

Open original article
Integrated multi-omics reveals ITGB2 drives the mesenchymal transition in glioblastoma via FAK signaling | PharmaRadar360